PHENOTYPIC STUDY OF RESISTANCE OF BETA-LACTAMASE-INHIBITOR-RESISTANT TEM ENZYMES WHICH DIFFER BY NATURALLY-OCCURRING VARIATIONS AND BY SITE-DIRECTED SUBSTITUTION AT ASP(276)
Mm. Canica et al., PHENOTYPIC STUDY OF RESISTANCE OF BETA-LACTAMASE-INHIBITOR-RESISTANT TEM ENZYMES WHICH DIFFER BY NATURALLY-OCCURRING VARIATIONS AND BY SITE-DIRECTED SUBSTITUTION AT ASP(276), Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1323-1328
At this time an amino acid substitution at position 276 in the TEM-1 e
nzyme is associated with an additional substitution at position 69 in
natural beta-lactamase-inhibitor-resistant (IRT) beta-lactamases. The
effect of the Asn(276)-->Asp substitution On resistance was assessed w
ith the Asn276Asp variant, generated by site-directed mutagenesis, The
mutant was resistant to beta-lactamase inhibitors, but the MICs of am
oxicillin combined with clavulanic acid or tazobactam were strikingly
different for E, coli strains producing the Asn276Asp variant and thos
e producing naturally occurring IRTs with single or double substitutio
ns. The inhibitory effects of clavulanic acid and tazobactam were the
same in IRTs with substitutions at position 69 (IRT-5 and IRT-6), The
effect of clavulanic acid on the MICs of amoxicillin for the Asn276Asp
variant was greater than that of tazobactam, In IRTs,vith double subs
titutions, at positions 69 plus 276 (IRT-4, IRT-7, and IRT-8) or 69 pl
us 275 (IRT-14), tazobactam was a more potent inhibitor than clavulani
c acid, The effect of the Asn(276)-->Asp substitution on the values of
the kinetic constants and the concentration required to inhibit by 50
% the hydrolysis of benzylpenicillin confirms that this single mutatio
n is responsible for resistance to beta-lactamase inhibitors. Molecula
r modeling of the Asn276Asp mutant shows that Asp(276) can form two sa
lt bonds with Arg(244) close to the penicillin-binding cavity, The add
ition of the Asp(276) mutation to that preexisting at position 69 conf
ers a higher selective advantage to bacteria, as shown by the reductio
n in p-lactamase inhibitor efficiencies of the double variants. Theref
ore, the emergence of multiple mutations in TEM beta-lactamases by vir
tue of the use of beta-lactamase inhibitors increases selection pressu
re resulting in the convergent evolution of resistant strains.